Global blood serum market is expected to grow at a positive CAGR in the upcoming years. Blood serum is a branch serology, which is used in the diagnostics tests and also in the blood typing. It is again used for diagnostics test which is centrifuged to remove the excess of material and cell mass, and cellular components and the clotting factors like thrombin, fibrinogen, prothrombin that’s stops the clot formation.
The protein fibrinogen in the blood plasma, causing the blood clot has also been removed. The blood plasma is without fibrinogens and the serum is a clear fluid and this part of blood and serum does not contain red blood cell and white blood cell and the clotting agent. Serum contains all the protein which is unused in the blood clotting or blood coagulation.Serum is very important part for embryonic stem cells regeneration and in serum there are some regenerative factors when combined with the cytokine. Blood Serum Market is segmented, By Product Type Porcine, Equine, Bovine (Calf, Newborn calf, Adult Bovine, Fetal Bovine) and Others.
Bovine serum is very useful and mostly preferred for the various experiments to test; it is used as the concentration of proteins in the experiments in most of the labs. And Bovine serum segment is going to expand high during the predicted period. Due to the high investment of the government in the research and development and novel technology the bovine serum segment is expected to rise at the high CAGR during the predicted period. Blood Serum Market is segmented, By Applications Cell Line Saving, Cell culture Media, Diagnostic Reagents, Tissue Culture, etc.
Blood Serum Market is segmented by Geographical Region the North American region consists of the U.S., and Canada. Latin America region consists of Mexico and Brazil. The Western European region consists of Germany, Italy, France, England and Spain. The Eastern European region consists of Poland and Russia. Asia Pacific region consists of China, India, ASEAN, Australia & New Zealand. The Middle East and Africa region consists of GCC, South Africa and North Africa.
Blood Serum Industry Key Players include Shire Plc., CSL Limited, Grifols, S.A., Lanzhou Minhai, Octa pharma Inc., Lanzhou Roya, Atlanta Biologicals, VWR, South Pacific Sera, Caoyuan Lvye, GE Healthcare, Wuhan Sanli, Sigma -Aldrich, Zhejiang Tianhang, Changchun Xinuo, Jin Yuan Kang, MRC.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Blood Serum in these regions, from 2013 to 2025 (forecast), covering
• North America
• Southeast Asia
Global Blood Serum market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
• Thermo Fisher (Life-Tech)
• Moregate Biotech
• South Pacific Sera
• Atlanta Biologicals
• Lanzhou Minhai
• Zhejiang Tianhang
• Jin Yuan Kang
• Wuhan Sanli
• Changchun Xinuo
• Caoyuan Lvye
• Lanzhou Roya
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Bovine (Fetal Bovine, Newborn Calf, Calf, Adult Bovine)
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
• Cell Culture Media
• Cell Line Saving
• Tissue Culture
• Diagnostic Reagents
Research Support Specialist, USA